The ETF tracks Nifty Pharma Index which is designed to reflect the behavior and performance of the pharmaceutical sector in India.

Nippon India Nifty Pharma ETF

Industry experts are hopeful of India’s trajectory as the US is facing shortages and backorders. They said with many blockbuster drugs were going off-patent between 2025 and 2029. “The Indian pharma industry will have a further growth opportunity in the form of generics.”

Indian drugmakers likely to gain under the new US government

Roquette Frères S.A. seeks CCI approval for acquiring IFF’s Pharma Solutions business, aiming to expand in India’s pharmaceutical sector.

Roquette seeks CCI nod for acquisition of IFF’s Pharma Solutions business

Minister Lokesh seeks Indian Ambassador’s cooperation to set up pharma companies in Andhra Pradesh, highlighting investment opportunities.

Lokesh seeks cooperation of Indian envoy in Swiss for investments in pharma sector in A.P.

The Nifty Pharma index closed 0.55 per cent at 22182.40.

Stock market update: Nifty Pharma index 0.55%

The Nifty Pharma index was trading 0.13 per cent at 22033.60.

Stock market update: Nifty Pharma index 0.13% in an upbeat market

India’s pharmaceutical industry holds immense promise, but experts and stakeholders assert that to unlock its full potential, the Budget 2025 must focus on providing R&D support and checking API imports.

Budget 2025: Pharma industry lays out a plan to curb Chinese dependence

In today’s VUCA world, India’s pharmaceutical industry plays a crucial role in US healthcare, supplying cost-effective generic medicines and biosimilars. The partnership promises economic and national security benefits through diversified supply chains, and joint manufacturing initiatives, setting a global precedent for resilient and accessible healthcare systems.

Indo-US pharma alliance: Time to up the game

The Nifty Pharma index closed 0.69 per cent at 22061.70.

Stock market update: Nifty Pharma index 0.69%

The Nifty Pharma index was trading 0.07 per cent at 21895.35.

Stock market update: Nifty Pharma index 0.07% in a weak market

The Nifty Pharma index closed 0.29 per cent at 21909.75.

Stock market update: Nifty Pharma index 0.29%

The Nifty Pharma index was trading 0.26 per cent at 21915.80.

Stock market update: Nifty Pharma index 0.26% in an upbeat market

Nifty Pharma Index is designed to reflect the behavior and performance of the pharmaceutical sector in India. The rescheduling of index constituents happens bi-annually every year.

Nifty Pharma Index